Abstract | BACKGROUND: Recent studies point out a probable role of streptococcal antigens in the pathogenesis of Behçet's disease (BD). This has led to the proposal of benzathine penicillin as a therapeutic modality in BD. OBJECTIVE: METHODS: RESULTS: CONCLUSION:
|
Authors | M Calgüneri, I Ertenli, S Kiraz, M Erman, I Celik |
Journal | Dermatology (Basel, Switzerland)
(Dermatology)
Vol. 192
Issue 2
Pg. 125-8
( 1996)
ISSN: 1018-8665 [Print] Switzerland |
PMID | 8829493
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Gout Suppressants
- Penicillins
- Penicillin G Benzathine
- Colchicine
|
Topics |
- Adult
- Behcet Syndrome
(drug therapy, physiopathology, prevention & control)
- Colchicine
(administration & dosage, therapeutic use)
- Drug Therapy, Combination
- Female
- Gout Suppressants
(administration & dosage, therapeutic use)
- Humans
- Injections, Intramuscular
- Male
- Middle Aged
- Mouth Mucosa
(drug effects, pathology)
- Multivariate Analysis
- Penicillin G Benzathine
(administration & dosage, therapeutic use)
- Penicillins
(administration & dosage, therapeutic use)
- Prospective Studies
- Treatment Outcome
|